Literature DB >> 11413310

Multiple cis regulatory elements control RANTES promoter activity in alveolar epithelial cells infected with respiratory syncytial virus.

A Casola1, R P Garofalo, H Haeberle, T F Elliott, R Lin, M Jamaluddin, A R Brasier.   

Abstract

Respiratory syncytial virus (RSV) produces intense pulmonary inflammation, in part through its ability to induce chemokine synthesis in infected airway epithelial cells. RANTES (regulated upon activation, normally T-cell expressed and presumably secreted) is a CC chemokine which recruits and activates monocytes, lymphocytes, and eosinophils, all cell types present in the lung inflammatory infiltrate induced by RSV infection. In this study, we analyzed the mechanism of RSV-induced RANTES promoter activation in human type II alveolar epithelial cells (A549 cells). Promoter deletion and mutagenesis experiments indicate that RSV requires the presence of five different cis regulatory elements, located in the promoter fragment spanning from -220 to +55 nucleotides, corresponding to NF-kappaB, C/EBP, Jun/CREB/ATF, and interferon regulatory factor (IRF) binding sites. Although site mutations of the NF-kappaB, C/EBP, and CREB/AP-1 like sites reduce RSV-induced RANTES gene transcription to 50% or less, only mutations affecting IRF binding completely abolish RANTES inducibility. Supershift and microaffinity isolation assays were used to identify the different transcription factor family members whose DNA binding activity was RSV inducible. Expression of dominant negative mutants of these transcription factors further established their central role in virus-induced RANTES promoter activation. Our finding that the presence of multiple cis regulatory elements is required for full activation of the RANTES promoter in RSV-infected alveolar epithelial cells supports the enhanceosome model for RANTES gene transcription, which is absolutely dependent on binding of IRF transcription factors. The identification of regulatory mechanisms of RANTES gene expression is fundamental for rational design of inhibitors of RSV-induced lung inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413310      PMCID: PMC114366          DOI: 10.1128/JVI.75.14.6428-6439.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

Review 1.  Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation.

Authors:  M D Lane; Q Q Tang; M S Jiang
Journal:  Biochem Biophys Res Commun       Date:  1999-12-29       Impact factor: 3.575

2.  ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages.

Authors:  T Tamura; T Nagamura-Inoue; Z Shmeltzer; T Kuwata; K Ozato
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

3.  Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression.

Authors:  A Casola; R P Garofalo; M Jamaluddin; S Vlahopoulos; A R Brasier
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells.

Authors:  M Jamaluddin; S Wang; R P Garofalo; T Elliott; A Casola; S Baron; A R Brasier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-02       Impact factor: 5.464

5.  Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors.

Authors:  P Génin; M Algarté; P Roof; R Lin; J Hiscott
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

6.  Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3.

Authors:  M J Servant; B ten Oever; C LePage; L Conti; S Gessani; I Julkunen; R Lin; J Hiscott
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  Respiratory syncytial viral infection in infants with congenital heart disease.

Authors:  N E MacDonald; C B Hall; S C Suffin; C Alexson; P J Harris; J A Manning
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

8.  Respiratory syncytial virus. I. Concentration and purification of the infectious virus.

Authors:  O Ueba
Journal:  Acta Med Okayama       Date:  1978-08       Impact factor: 0.892

9.  Risk of primary infection and reinfection with respiratory syncytial virus.

Authors:  W P Glezen; L H Taber; A L Frank; J A Kasel
Journal:  Am J Dis Child       Date:  1986-06

10.  Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.

Authors:  E B Traenckner; H L Pahl; T Henkel; K N Schmidt; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  44 in total

1.  Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.

Authors:  Michael E Speer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  TAK1 regulates NF-ΚB and AP-1 activation in airway epithelial cells following RSV infection.

Authors:  Nilay Dey; Tianshuang Liu; Roberto P Garofalo; Antonella Casola
Journal:  Virology       Date:  2011-08-10       Impact factor: 3.616

3.  Cigarette smoke condensate enhances respiratory syncytial virus-induced chemokine release by modulating NF-kappa B and interferon regulatory factor activation.

Authors:  Shawn Monique Castro; Deepthi Kolli; Antonieta Guerrero-Plata; Roberto P Garofalo; Antonella Casola
Journal:  Toxicol Sci       Date:  2008-08-22       Impact factor: 4.849

4.  Respiratory syncytial virus-inducible BCL-3 expression antagonizes the STAT/IRF and NF-kappaB signaling pathways by inducing histone deacetylase 1 recruitment to the interleukin-8 promoter.

Authors:  Mohammad Jamaluddin; Sanjeev Choudhary; Shaofei Wang; Antonella Casola; Ruksana Huda; Roberto P Garofalo; Sutapa Ray; Allan R Brasier
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells.

Authors:  Tetsuya Homma; Satoshi Matsukura; Takashi Hirose; Tsukasa Ohnishi; Teruaki Kimura; Masatsugu Kurokawa; Koushi Ieki; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Masayuki Sato; Mio Kawaguchi; Robert P Schleimer; Mitsuru Adachi
Journal:  Int Arch Allergy Immunol       Date:  2010-06-04       Impact factor: 2.749

6.  TIF1beta functions as a coactivator for C/EBPbeta and is required for induced differentiation in the myelomonocytic cell line U937.

Authors:  J W Rooney; K L Calame
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

7.  Interferon regulatory factor 6 differentially regulates Toll-like receptor 2-dependent chemokine gene expression in epithelial cells.

Authors:  Mei Qi Kwa; Thao Nguyen; Jennifer Huynh; Divya Ramnath; Dominic De Nardo; Pui Yeng Lam; Eric C Reynolds; John A Hamilton; Matthew J Sweet; Glen M Scholz
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

8.  Role of hydrogen sulfide in paramyxovirus infections.

Authors:  Hui Li; Yinghong Ma; Oliver Escaffre; Teodora Ivanciuc; Narayana Komaravelli; John P Kelley; Ciro Coletta; Csaba Szabo; Barry Rockx; Roberto P Garofalo; Antonella Casola
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

9.  Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.

Authors:  Sif Hansdottir; Martha M Monick; Nina Lovan; Linda Powers; Alicia Gerke; Gary W Hunninghake
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

10.  Suppression of proinflammatory cytokine expression by herpes simplex virus type 1.

Authors:  Trine H Mogensen; Jesper Melchjorsen; Lene Malmgaard; Antonella Casola; Søren R Paludan
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.